- Home
- QURE vs DHT Comparison
QURE vs DHT Comparison
Compare QURE & DHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QURE | DHT |
|---|---|---|
| Founded | 1998 | 2005 |
| Country | Netherlands | Bermuda |
| Employees | 248 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.9B |
| IPO Year | 2013 | 2005 |
Fundamental Metrics
Financial Performance| Metric | QURE | DHT |
|---|---|---|
| Price | $22.42 | $24.51 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 6 |
| Target Price | ★ $61.24 | $24.85 |
| AVG Volume (30 Days) | 2.5M | ★ 4.7M |
| Earning Date | 11-09-2026 | 11-06-2026 |
| Dividend Yield | N/A | ★ 7.71% |
| EPS Growth | ★ 29.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $13,107,000.00 | N/A |
| Revenue This Year | $54.78 | $79.20 |
| Revenue Next Year | $356.14 | N/A |
| P/E Ratio | ★ N/A | $12.73 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.73 | $11.64 |
| 52 Week High | $71.50 | $26.91 |
Technical Indicators
Market Signals| Indicator | QURE | DHT |
|---|---|---|
| Relative Strength Index (RSI) | 28.08 | 58.64 |
| Support Level | $22.32 | $16.83 |
| Resistance Level | $25.61 | $26.91 |
| Average True Range (ATR) | 1.19 | 1.07 |
| MACD | 0.75 | -0.15 |
| Stochastic Oscillator | 57.58 | 49.28 |
Price Performance
Historical ComparisonAbout QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.
About DHT DHT Holdings Inc.
DHT Holdings Inc is a crude oil tanker company. The company's primary business is operating a fleet of crude oil tankers, with a secondary activity of providing technical management services. Its fleet trades internationally and consists of VLCC crude oil tankers. The group generates revenues from time charter and spot market operations. It operates vessels through its subsidiary management companies in Monaco, Norway, Singapore, and India. The company generates the majority of its revenue from Voyage charter revenues.